Caribou Biosciences (CRBU)
(Delayed Data from NSDQ)
$2.04 USD
-0.06 (-2.86%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $2.05 +0.01 (0.49%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Caribou Biosciences, Inc. has a market cap of $195.31M, which represents its share price of $2.10 multiplied by its outstanding shares number of 93.00M. As a small-cap company, CRBU's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CRBU 2.04 -0.06(-2.86%)
Will CRBU be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRBU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRBU
Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates
Caribou Biosciences (CRBU) Upgraded to Buy: Here's What You Should Know
CRBU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know
Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know
Other News for CRBU
Caribou Biosciences: Key Data Updates Coming, But I'm Concerned About Near-Term Volatility
Caribou Biosciences Regains Nasdaq Compliance
Caribou Biosciences Confirms Director Elections and Auditor
Bank of America Securities Reaffirms Their Buy Rating on Caribou Biosciences (CRBU)
Caribou Biosciences (CRBU) Receives a Hold from Evercore ISI